Scopulariopsis, a poorly known opportunistic fungus: Spectrum of species in clinical samples and in vitro responses to antifungal drugs

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 3937-3943

  Sandoval Denis, Marcelo ^a   Sutton, Deanna A ^b   Fothergill, Annette W ^b   Cano Lira, Josep ^a   Gené, Josepa ^a   Decock, C A ^c   De Hoog, G S ^d   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ELONGATION FACTOR 1ALPHA; ITRACONAZOLE; POSACONAZOLE; RNA 28S; TERBINAFINE; VORICONAZOLE;

28S RRNA GENE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BODY FLUID; DRUG RESPONSE; ELONGATION FACTOR 1ALPHA GENE; FUNGAL STRAIN; FUNGAL STRUCTURES; FUNGUS ISOLATION; IN VITRO STUDY; MICROASCUS; MICROASCUS CINEREUS; MICROASCUS CIRROSUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SCOPULARIOPSIS; SCOPULARIOPSIS BREVICAULIS; SCOPULARIOPSIS BRUMPTII; SCOPULARIOPSIS CANDIDA; SCOPULARIOPSIS GRACILIS;

ANTIFUNGAL AGENTS; CLUSTER ANALYSIS; DNA, FUNGAL; DNA, RIBOSOMAL; GENES, RRNA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOLOGICAL TYPING TECHNIQUES; MYCOSES; PEPTIDE ELONGATION FACTOR 1; PHYLOGENY; RNA, FUNGAL; RNA, RIBOSOMAL; SCOPULARIOPSIS; SEQUENCE ANALYSIS, DNA;

EID: 84889782818     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01927-13     Document Type: Article

References (41)

1. Barron GL, Cain RF, Gilman JC. 1961. The genus Microascus. Can. J. Botany 39:1609-1631.
2. Morton FJ, Smith G. 1963. The genera Scopulariopsis Bainier, Microascus Zukal, and Doratomyces Corda. Mycol. Pap. 86:1-96.
3. Samson RA, Houbraken J, Thrane U, Frisvad JC, Andersen B (ed). 2010. Food and indoor fungi. CBS Laboratory Manual Series 2. CBSKNAW Fungal Biodiversity Centre, Utrecht, The Netherlands.
4. Tosti A, Piraccini BM, Stinchi C, Lorenzi S. 1996. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals. Br. J. Dermatol. 135:799-802.
5. de Hoog GS, Guarro J, Gené J, Figueras MJ. 2001. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
6. Ragge NK, Hart JC, Easty DL, Tyers AG. 1990. A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty. Br. J. Ophthalmol. 74:561-562.
7. Neglia JP, Hurd DD, Ferrieri P, Snover DC. 1987. Invasive Scopulariopsis in the immunocompromised host. Am. J. Med. 83:1163-1166.
8. Wheat LJ, Bartlett M, Ciccarelli M, Smith JW. 1984. Opportunistic Scopulariopsis pneumonia in an immunocompromised host. South. Med. J. 77:1608-1609.
9. Gariano RF, Kalina RE. 1997. Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis. Retina 17:256-258.
10. Patel R, Gustaferro CA, Krom RA, Wiesner RH, Roberts GD, Paya CV. 1993. Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient. Clin. Infect. Dis. 19:198-200.
11. Petit A, Levine E, Epaud R, Le Pointe HD, Angoulvant A. 2011. Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia. Lancet Infect. Dis. 11:416. doi:10.1016/S1473-3099(10)70249-8.
12. Kriesel JD, Adderson EE, Gooch WM, III, Pavia AT. 1994. Invasive sinonasal disease due to Scopulariopsis candida: case report and review of Scopulariopsis. Clin. Infect. Dis. 19:317-319.
13. Vaidya PS, Levine JF. 1992. Scopulariopsis peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. Perit. Dial. Int. 12:78-79.
14. Migrino RQ, Hall GS, Longworth DL. 1995. Deep tissue infections caused by Scopulariopsis brevicaulis: report of a case of prosthetic valve endocarditis and review. Clin. Infect. Dis. 21:672-674.
15. Jain D, Oberoi JK, Shahi SK, Shivnani G, Wattal C. 2011. Scopulariopsis brevicaulis infection of prosthetic valve resembling aspergilloma on histopathology. Cardiovasc. Pathol. 20:381-383.
16. Abbott SP, Sigler L. 2001. Heterothallism in the Microascaceae demonstrated by three species in the Scopulariopsis brevicaulis series. Mycologia 93:1211-1220.
17. Iwen P, Schutte SD, Florescu DF, Noel-Hurst RK, Sigler L. 2012. Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species. Med. Mycol. 50:561-569.
18. Yang Q, Wei J, Chen Z. 2012. Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient. Diagn. Microbiol. Infec. Dis. 73:369-371.
19. Hawksworth DL. 2012. Managing and coping with names of pleomorphic fungi in a period of transition. IMA Fungus 3:15-24.
20. Steinbach WJ, Schell WA, Miller JL, Perfect JR, Martin PL. 2004. Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. J. Infect. 48:112-116.
21. Gluck O, Segal N, Yariv F, Polacheck I, Puterman M, Greenberg D, Daniel B. 2011. Pediatric invasive sinonasal Scopulariopsis brevicaulis-A case report and literature review. Int. J. Pediatr. Otorhinolaryngol. 75: 891-893.
22. Miossec C, Morio F, Lepoivre T, Le Pape P, Garcia-Hermoso D, Gay-Andrieu F, Haloun A, Treilhaud M, Leclair F, Miegeville M. 2011. Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis. J. Clin. Microbiol. 49:2743-2747.
23. Ropars J, Cruaud C, Lacoste S, Dupont J. 2012. A taxonomic and ecological overview of cheese fungi. Int. J. Food Microbiol. 155:199-210.
24. Aguilar C, Pujol I, Guarro J. 1999. In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob. Agents Chemother. 43:1520-1522.
25. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago M, Monzón A, Rodriguez-Tudela J. 2003. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob. Agents Chemother. 47:2339-2341.
26. Guarro J, Gené J, Stchigel AM, Figueras MJ. 2012. Atlas of soil ascomycetes. CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands.
27. O'Donnell K. 1993. Fusarium and its near relatives, p 225-233. In Reynolds DR, Taylor JW (ed). The fungal holomorph: mitotic, meiotic and pleomorphic speciation in fungal systematics. CAB International, Wallingford, United Kingdom.
28. Rehner SA, Buckley E. 2005. A Beauveria phylogeny inferred from nuclear ITS and EF1- sequences: evidence for cryptic diversification and links to Cordyceps teleomorphs. Mycologia 97:84-98.
29. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA 5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
30. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
31. Castresana J. 2000. Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol. Biol. Evol. 17:540-552.
32. Swofford DL. 2003. PAUP: phylogenetic analysis using parsimony (and other methods), version 4. Sinauer Associates, Sunderland, MA.
33. Darriba D, Taboada GL, Doallo R, Posada D. 2012. jModelTest 2: more models, new heuristics and parallel computing. Nat. Methods 9:772. doi: 10.1038/nmeth.2109.
34. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard-. 2nd ed. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
35. Mohammedi I, Piens M, Audigier-Valette C, Gantier JC, Argaud L, Martin O, Robert D. 2004. Fatal Microascus trigonosporus (anamorph Scopulariopsis) pneumonia in a bone marrow transplant recipient. Eur. J. Clin. Microbiol. Infect. Dis. 23:215-217.
36. Wang P, Wang H, Zhao Y, Zhang XJ, Xu YC. 2011. A case of endocarditis caused by Microascus trigonosporus. Chin. J. Mycol. 6:162-165.
37. Johnson E, Szekely A, Warnock D. 1999. In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens. Antimicrob. Agents Chemother. 43:1260-1263.
38. Carrillo-Muñoz AJ, Guglietta A, Palacín B, Casals J, del Valle O, Guardià C, Rodriguez V, Quindós G. 2004. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis. Chemotherapy 50:308-313.
39. Carrillo-Muñoz AJ, Giusiano G, Guarro J, Quindós G, Guardia C, del Valle O, Rodríguez V, Estivill D, Ćrdenes CD. 2007. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int. J. Antimicrob. Agents 30:157-161.
40. Gilgado F, Serena C, Cano J, Gené J, Guarro J. 2006. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob. Agents Chemother. 50:4211-4213.
41. Beltrame A, Sarmati L, Cudillo L, Cerretti R, Picardi A, Anemona L, Fontana C, Andreoni M, Arcese W. 2009. A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. Int. J. Infect. Dis. 13:488-492.